Can a smartphone app bridge the mental health care gap?

NCT ID NCT07778680

Ongoing Symptom relief Sponsor: Institute of Mental Health, Singapore Source: ClinicalTrials.gov ↗

Running, but no longer taking on new participants.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether a mindfulness app called AmDTx (now DawnDTx) can help reduce symptoms of anxiety and depression in people who are on a waiting list for their first psychiatric consultation. Participants will be randomly assigned to use either the mindfulness app or a placebo app during the wait. The study measures changes in anxiety (GAD7) and depression (PHQ8) scores to see if the app provides meaningful relief while they await professional care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: A mobile mental health app called AmDTx (also known as DawnDTx) that provides mindfulness-based exercises and content.
What this could lead to: If effective, this app could offer a practical, low-cost way to support people waiting for mental health care, potentially reducing symptoms before their first appointment.
What could go wrong: The trial is relatively small and early, and the app may not outperform a placebo. Also, benefits might vary depending on individual engagement and the severity of symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 122 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * -Waitlisted for outpatient psychosocial programming or psychiatric services at IMH or SGH * Age range: IMH: 13 and above; SGH: 21 and above * Language: Fluency in English (to complete assessments) * Understanding and willingness to comply with study requirements / capable of providing informed consent (e.g., autonomously or with guardian support) * Comfortable with smartphone or tablet, downloading and running the AmDTx platform, and at least periodic access to the internet. Exclusion Criteria: * Any known practical factors that would preclude participation (e.g., extended absences) in the study. * Serious medical condition that precludes participation in this study. * Intellectual disability (as evidenced by attending a special school for intellectual disability) * Participation in another treatment/intervention study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY AND DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression depressive disorder mixed anxiety and depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY AND DEPRESSION DEPRESSION ANXIETY DISORDER

Contacts and locations

Locations

Institute of Mental Health

Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.